Wakamoto Pharmaceutical Co.,Ltd. Share Price

Equities

4512

JP3991200001

Pharmaceuticals

Market Closed - Japan Exchange 11:30:00 31/05/2024 am IST 5-day change 1st Jan Change
254 JPY +0.40% Intraday chart for Wakamoto Pharmaceutical Co.,Ltd. +4.10% +19.25%

Financials

Sales 2011 9.67B 61.43M 5.13B Sales 2012 9.43B 59.92M 5B Capitalization 8.59B 54.6M 4.56B
Net income 2011 -425M -2.7M -225M Net income 2012 -222M -1.41M -118M EV / Sales 2011 0.9 x
Net cash position 2011 156M 991K 82.71M Net cash position 2012 212M 1.35M 112M EV / Sales 2012 0.89 x
P/E ratio 2011
-20.8 x
P/E ratio 2012
-38.7 x
Employees 403
Yield 2011 *
-
Yield 2012
-
Free-Float 63.42%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.40%
1 week+4.10%
1 month+10.43%
3 months+24.51%
6 months+27.64%
Current year+19.25%
More quotes
1 week
243.00
Extreme 243
257.00
1 month
228.00
Extreme 228
257.00
Current year
197.00
Extreme 197
257.00
1 year
189.00
Extreme 189
261.00
3 years
189.00
Extreme 189
410.00
5 years
188.00
Extreme 188
754.00
10 years
188.00
Extreme 188
754.00
More quotes
Managers TitleAgeSince
President 65 01/10/01
Director/Board Member 58 01/88/01
Director/Board Member 67 01/79/01
Members of the board TitleAgeSince
Director/Board Member 70 01/16/01
Director/Board Member 67 01/79/01
President 65 01/10/01
More insiders
Date Price Change Volume
31/24/31 254 +0.40% 42,700
30/24/30 253 -.--% 34,700
29/24/29 253 +0.80% 76,800
28/24/28 251 +1.21% 108,300
27/24/27 248 +1.64% 100,100

Delayed Quote Japan Exchange, May 31, 2024 at 11:30 am IST

More quotes
WAKAMOTO PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of ethical drugs such as gastrointestinal drugs and non-prescription drugs. The Company operates through four business segments. The Pharmaceuticals segment is involved in the manufacture and sale of innovator drugs, generic drugs and optiaid series supplements mainly in the ophthalmic field, as well as the commission of production and the sale of diagnostic drugs and raw materials in Japan. The Healthcare segment sales its core product Kawakami Wakamoto, the Avantbise series of medicated toothpastes that promote bad breath prevention based on evidence and Avantbise Oral Tablet mainly in the mail order business. The International segment is involved in the business related to the export of products and raw materials mainly in Asia and Europe, as well as the new license in and out business. The Real Estate Leasing segment is involved in the rental business of Coredo Muromachi.
More about the company